India’s 1st needle-free intranasal COVID-19 vaccine get emergency use approval from DCGI
India’s 1st Intranasal COVID-19 vaccine: Bharat Biotech has received emergency use authorization for India’s 1st needle-free intranasal COVID-19 vaccine. DCGI granting approval for the first intranasal vaccine comes as a major milestone in India’s fight against the COVID-19 pandemic.
from Jagran Josh https://ift.tt/js6rRpK
via IFTTT
Comments
Post a Comment